A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

NCT05362058 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

928

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Type 2 Diabetes

Interventions

DRUG: Insulin Efsitora Alfa
DRUG: Insulin Degludec

Sponsor

Eli Lilly and Company